OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Carbazole-based semicarbazones and hydrazones as multifunctional anti-Alzheimer agents
Kishan B. Patel, Dushyant V. Patel, Nirav R. Patel, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 20, pp. 10278-10299
Open Access | Times Cited: 12
Kishan B. Patel, Dushyant V. Patel, Nirav R. Patel, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 20, pp. 10278-10299
Open Access | Times Cited: 12
Showing 12 citing articles:
Innovative approaches to Alzheimer's therapy: Harnessing the power of heterocycles, oxidative stress management, and nanomaterial drug delivery system
Mohammad Umar, Yasir Rehman, Subiya Ambreen, et al.
Ageing Research Reviews (2024) Vol. 97, pp. 102298-102298
Closed Access | Times Cited: 7
Mohammad Umar, Yasir Rehman, Subiya Ambreen, et al.
Ageing Research Reviews (2024) Vol. 97, pp. 102298-102298
Closed Access | Times Cited: 7
Development of novel 9H-carbazole-4H-chromene hybrids as dual cholinesterase inhibitors for the treatment of Alzheimer’s disease
Nissi Sharon, Vinod G. Ugale, Pannala Padmaja, et al.
Molecular Diversity (2024) Vol. 29, Iss. 1, pp. 379-396
Closed Access | Times Cited: 4
Nissi Sharon, Vinod G. Ugale, Pannala Padmaja, et al.
Molecular Diversity (2024) Vol. 29, Iss. 1, pp. 379-396
Closed Access | Times Cited: 4
Novel Drug Design for Treatment of COVID-19: A Systematic Review of Preclinical Studies
Sarah Mousavi, Shima Zare, Mahmoud Mirzaei, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2022) Vol. 2022, pp. 1-70
Open Access | Times Cited: 18
Sarah Mousavi, Shima Zare, Mahmoud Mirzaei, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2022) Vol. 2022, pp. 1-70
Open Access | Times Cited: 18
Insilico and invitro profiling of curcumin and its derivatives as a potent acetylcholinesterase inhibitor
Mukul Jain, Rupal Dhariwal, Krupanshi Bhardava, et al.
Biocatalysis and Agricultural Biotechnology (2024) Vol. 56, pp. 103022-103022
Closed Access | Times Cited: 3
Mukul Jain, Rupal Dhariwal, Krupanshi Bhardava, et al.
Biocatalysis and Agricultural Biotechnology (2024) Vol. 56, pp. 103022-103022
Closed Access | Times Cited: 3
Tridentate N-Acylhydrazones as Moderate Ligands for the Potential Management of Cognitive Decline Associated With Metal-Enhanced Neuroaggregopathies
Daphne S. Cukierman, Nicolás A. Rey
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 10
Daphne S. Cukierman, Nicolás A. Rey
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 10
Progress and Development of Carbazole Scaffold Based as Potential Anti- Alzheimer Agents Using MTDL Approach
Nitin Kumar, Pankaj Gupta, Sahil Bansal
Letters in Drug Design & Discovery (2022) Vol. 19, Iss. 12, pp. 1049-1067
Closed Access | Times Cited: 10
Nitin Kumar, Pankaj Gupta, Sahil Bansal
Letters in Drug Design & Discovery (2022) Vol. 19, Iss. 12, pp. 1049-1067
Closed Access | Times Cited: 10
Unveiling piperazine-quinoline hybrids as potential multi-target directed anti-Alzheimer’s agents: design, synthesis and biological evaluation
Afzal Nagani, Moksh Shah, Salman Patel, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 1
Afzal Nagani, Moksh Shah, Salman Patel, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 1
Role of Computational Modeling in Drug Discovery for Alzheimer’s Disease
Mange Ram Yadav, Prashant R. Murumkar, Rahul Barot, et al.
Challenges and advances in computational chemistry and physics (2023), pp. 57-107
Closed Access | Times Cited: 3
Mange Ram Yadav, Prashant R. Murumkar, Rahul Barot, et al.
Challenges and advances in computational chemistry and physics (2023), pp. 57-107
Closed Access | Times Cited: 3
Blood–brain barrier permeable benzylpiperidin‐4‐yl‐linked benzylamino benzamides as dual cholinesterase inhibitors
Razia Banoo, Vijay K. Nuthakki, Mohd Abdullaha, et al.
Drug Development Research (2022) Vol. 83, Iss. 8, pp. 1791-1802
Closed Access | Times Cited: 4
Razia Banoo, Vijay K. Nuthakki, Mohd Abdullaha, et al.
Drug Development Research (2022) Vol. 83, Iss. 8, pp. 1791-1802
Closed Access | Times Cited: 4
Unveiling Piperazine-Quinoline Hybrids as Potential Multi-Target Directed Anti- Alzheimer’s Agents: Design, Synthesis and Biological Evaluation
Afzal Nagani, Moksh Shah, Salman Patel, et al.
Research Square (Research Square) (2024)
Open Access
Afzal Nagani, Moksh Shah, Salman Patel, et al.
Research Square (Research Square) (2024)
Open Access
Novel Derivatives of Phenylisoxazole‐3/5‐Carbaldehyde Semicarbazone: Synthesis, Characterization, and Computational Studies
Fernando Carrasco, Wilfredo Hernández, Oscar Chupayo, et al.
Journal of Chemistry (2024) Vol. 2024, Iss. 1
Open Access
Fernando Carrasco, Wilfredo Hernández, Oscar Chupayo, et al.
Journal of Chemistry (2024) Vol. 2024, Iss. 1
Open Access
CHARACTERIZATION OF NOVEL CARPROFEN DERIVATIVES AS INHIBITORS OF THE SEROTONIN 5-HT2C RECEPTORS AND CLK4-KD PROTEIN KINASE FOR THE DEVELOPMENT OF PHARMACOLOGICALLY ACTIVE COMPOUNDS
Ana-Maria Udrea
FARMACIA (2023) Vol. 71, Iss. 6, pp. 1232-1240
Open Access
Ana-Maria Udrea
FARMACIA (2023) Vol. 71, Iss. 6, pp. 1232-1240
Open Access
